The global Johne’s disease diagnostics market size is estimated to reach USD 994.07 million by 2030, registering to grow at a CAGR of 6.21% from 2025 to 2030 according to a new report by Grand View Research, Inc. Growing awareness about Johne’s disease increases the number of diagnostic tests in animals, contributing to market growth. Moreover, the increasing prevalence of zoonotic diseases is another factor driving the market for Johne’s disease diagnostics. The increasing cattle population or livestock population is a major factor responsible for market growth. According to NCBI, the global cow population might grow from 1.5 billion to 2.6 billion between 2000 and 2050, while the global goat and sheep population could grow from 1.7 billion to 2.7 billion.
The COVID-19 pandemic has had a major impact on the global population, as well as companies and sectors in a variety of ways. To deal with the dilemma, the healthcare profession has been forced to develop both therapeutic and preventative measures. The pandemic has had a wide-ranging impact on many aspects of life, including the veterinary sector, necessitating a delicate balancing act between animal welfare and public health. Johne’s disease diagnostics sector, like other markets, has been severely impacted. Supply chain disruptions, poor demand, and operational challenges owing to shifting laws and restrictions are some of the key negative effects of COVID-19 on the market.
Furthermore, factors driving the market include the presence of numerous animal health and diagnostics companies and a rise in veterinary healthcare expenditure which is expected to accelerate the growth of the market. Furthermore, the presence of healthcare programs and a rise in the number of initiatives to promote animal health are factors anticipated to increase the growth potential in this region. Efficient measures undertaken by animal welfare organizations in case of an emergency or sudden disease outbreak are also expected to contribute to market growth across the globe. Moreover, well-developed infrastructure and high R&D spending in the region are factors anticipated to boost the market.
Many new diagnostic tests are expected to be introduced in the market over the next few years. Local players and online sales of these devices and kits present major sources of competition. Existing players are enhancing their portfolios with technologically advanced products and are widening their geographic reach by acquiring smaller local players. For instance, in July 2020, VMRD, Inc. received USDA approval for the testing of goat serum on its Johne’s Antibody Test Kit. This new development complemented the USDA's existing licensing for bovine serum and milk samples, for which, this test can be widely utilized in laboratories throughout the U.S. and the world.
Request a free sample copy or view report summary: Johne’s Disease Diagnostics Market Report
The cattle segment dominated the market and accounted for the largest revenue share of more than 87% in 2024.
Veterinary hospitals and clinics dominated the market with the largest revenue share of over 53% in 2024. Hospitals and clinics have the infrastructure to conduct various diagnostic tests, such as ELISA and PCR, that detect Johne’s disease.
The PCR segment dominated the market and accounted for over 36.0% in 2024. The swift acceptance of testing and diagnostic technologies, as well as the increase in the livestock population, are the primary drivers anticipated to fuel the segment growth.
North America Johne’s disease diagnostics market dominated the global market and accounted for the largest revenue share of more than 32.0% in 2024.
Grand View Research has segmented the global Johne’s disease diagnostics market based on animal type, test type, end-use, and region:
Johne's Disease Diagnostics Animal Type Outlook (Revenue, USD Million, 2018 - 2030)
Cattle
Goat
Sheep
Johne's Disease Diagnostics Test Type Outlook (Revenue, USD Million, 2018 - 2030)
ELISA
PCR
AGID
Johne's Disease Diagnostics End-use Outlook (Revenue, USD Million, 2018 - 2030)
Veterinary Hospitals & Clinics
Others
Johne's Disease Diagnostics Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Rest of Europe
Asia Pacific
Japan
India
China
South Korea
Australia
Thailand
Rest of Asia Pacific
Latin America
Brazil
Argentina
Rest of Latin America
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
Rest of MEA
List of Key Players in Johne's Disease Diagnostics Market
Thermo Fisher Scientific, Inc.
PBD Biotech
Zoetis
IDEXX Laboratories
IDVET
VMRD Inc.
Biomeriux SA.
INDICAL BIOSCIENCE GmbH
MV Diagnostics (Sure Farm Ltd)
Tetracore, Inc.
"The quality of research they have done for us has been excellent..."